This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Bioverativ Therapeutics Inc., Fondazione Telethon, Ospedale San Raffaele S.r.l.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2025
Title: Isidro Zarraga: Innovator in Lentiviral Vector Formulations
Introduction
Isidro Zarraga is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of lentiviral vector formulations. His work focuses on improving the stability of these formulations for systemic administration, which has important implications for treating various disorders.
Latest Patents
Zarraga holds a patent for "Lentiviral vector formulations." This patent encompasses lentiviral vector (LV) formulations and pharmaceutical compositions that exhibit enhanced stability and are suitable for systemic administration. Additionally, the patent outlines methods for treating disorders, especially blood disorders, through the systemic administration of these LV formulations.
Career Highlights
Throughout his career, Isidro Zarraga has worked with prominent organizations in the biotechnology sector. He has been associated with Bioverativ Therapeutics Inc., where he contributed to advancements in therapeutic solutions. He has also worked with Fondazione Telethon, furthering research in genetic disorders and innovative treatments.
Collaborations
One of Zarraga's notable collaborators is Andrew Kroetsch. Their partnership has likely fostered innovative ideas and advancements in their respective fields.
Conclusion
Isidro Zarraga's contributions to lentiviral vector formulations highlight his role as an influential inventor in biotechnology. His work continues to pave the way for new treatment methodologies, showcasing the importance of innovation in addressing complex medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile